新型コロナウイルス感染症検査キットのアジア太平洋市場2021年-2025年

◆英語タイトル:Coronavirus Test Kits Market in APAC 2021-2025
◆商品コード:IRTNTR43239
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年5月25日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は、新型コロナウイルス感染症検査キットのアジア太平洋市場規模が2021年から2025年まで年平均-17%以上減少し、24.8億ドルまで衰退すると予測しています。本調査資料ではアジア太平洋の新型コロナウイルス感染症検査キット市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
【レポートの概要】

Coronavirus Test Kits Market in APAC 2021-2025
Technavio has been monitoring the coronavirus test kits market in APAC and it is poised to decline by $ 2.48 bn during 2021-2025, progressing at a CAGR of over -17% during the forecast period. Our report on coronavirus test kits market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current APAC market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of coronavirus and new product launches. In addition, the increasing incidence of coronavirus is anticipated to boost the growth of the market as well.

The coronavirus test kits market in APAC analysis includes end-user segment and geographic landscape.
Technavio’s coronavirus test kits market in APAC is segmented as below:

By End-user
• Government
• Non-government

By Geography
• India
• China
• Japan
• South Korea (Republic of Korea)
• Rest of APAC

This study identifies the government initiative in creating awareness about coronavirus as one of the prime reasons driving the coronavirus test kits market in APAC growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on coronavirus test kits market in APAC covers the following areas:
• Coronavirus test kits market in APAC sizing
• Coronavirus test kits market in APAC forecast
• Coronavirus test kits market in APAC industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in APAC vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co Diagnostics Inc., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the coronavirus test kits market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/test-kits-for-corona-virus-testing-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Government – Market size and forecast 2020-2025
o Non-government – Market size and forecast 2020-2025
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o India – Market size and forecast 2020-2025
o China – Market size and forecast 2020-2025
o Japan – Market size and forecast 2020-2025
o South Korea (Republic of Korea) – Market size and forecast 2020-2025
o Rest of APAC – Market size and forecast 2020-2025
o Market opportunity by geography
• Drivers Challenges and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o 3D Biomedicine Science and Technology Co. Ltd.
o Abbott Laboratories
o BGI Genomics Co. Ltd.
o Co Diagnostics Inc.
o F. Hoffmann La Roche Ltd.
o Guangzhou Wondfo Biotech Co. Ltd.
o Maccura Biotechnology Co. Ltd.
o Mylab Discovery Solutions Pvt Ltd.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Parent market
• 8: Market characteristics
• 9: Offerings of vendors included in the market definition
• 10: Market segments
• 11: Global – Market size and forecast 2020 – 2025 ($ million)
• 12: Global market: Year-over-year growth 2020 – 2025 (%)
• 13: Five forces analysis 2020 & 2025
• 14: Bargaining power of buyers
• 15: Bargaining power of suppliers
• 16: Threat of new entrants
• 17: Threat of substitutes
• 18: Threat of rivalry
• 19: Market condition – Five forces 2020
• 20: End user – Market share 2020-2025 (%)
• 21: Comparison by End user
• 22: Government – Market size and forecast 2020-2025 ($ million)
• 23: Government – Year-over-year growth 2020-2025 (%)
• 24: Non-government – Market size and forecast 2020-2025 ($ million)
• 25: Non-government – Year-over-year growth 2020-2025 (%)
• 26: Market opportunity by End user
• 27: Customer landscape
• 28: Market share by geography 2020-2025 (%)
• 29: Geographic comparison
• 30: India – Market size and forecast 2020-2025 ($ million)
• 31: India – Year-over-year growth 2020-2025 (%)
• 32: China – Market size and forecast 2020-2025 ($ million)
• 33: China – Year-over-year growth 2020-2025 (%)
• 34: Japan – Market size and forecast 2020-2025 ($ million)
• 35: Japan – Year-over-year growth 2020-2025 (%)
• 36: South Korea (Republic of Korea) – Market size and forecast 2020-2025 ($ million)
• 37: South Korea (Republic of Korea) – Year-over-year growth 2020-2025 (%)
• 38: Rest of APAC – Market size and forecast 2020-2025 ($ million)
• 39: Rest of APAC – Year-over-year growth 2020-2025 (%)
• 40: Key leading countries
• 41: Market opportunity by geography ($ million)
• 42: Impact of drivers and challenges
• 43: Vendor landscape
• 44: Landscape disruption
• 45: Industry risks
• 46: Vendors covered
• 47: Market positioning of vendors
• 48: 3D Biomedicine Science and Technology Co. Ltd. – Overview
• 49: 3D Biomedicine Science and Technology Co. Ltd. – Product and service
• 50: 3D Biomedicine Science and Technology Co. Ltd. – Key offerings
• 51: 3D Biomedicine Science and Technology Co. Ltd. – Key customers
• 52: 3D Biomedicine Science and Technology Co. Ltd. – Segment focus
• 53: Abbott Laboratories – Overview
• 54: Abbott Laboratories – Business segments
• 55: Abbott Laboratories – Key offerings
• 56: Abbott Laboratories – Key customers
• 57: Abbott Laboratories – Segment focus
• 58: BGI Genomics Co. Ltd. – Overview
• 59: BGI Genomics Co. Ltd. – Product and service
• 60: BGI Genomics Co. Ltd. – Key offerings
• 61: BGI Genomics Co. Ltd. – Key customers
• 62: BGI Genomics Co. Ltd. – Segment focus
• 63: Co Diagnostics Inc. – Overview
• 64: Co Diagnostics Inc. – Business segments
• 65: Co Diagnostics Inc. – Key offerings
• 66: Co Diagnostics Inc. – Key customers
• 67: Co Diagnostics Inc. – Segment focus
• 68: F. Hoffmann La Roche Ltd. – Overview
• 69: F. Hoffmann La Roche Ltd. – Business segments
• 70: F. Hoffmann La Roche Ltd. – Key offerings
• 71: F. Hoffmann La Roche Ltd. – Key customers
• 72: F. Hoffmann La Roche Ltd. – Segment focus
• 73: Guangzhou Wondfo Biotech Co. Ltd. – Overview
• 74: Guangzhou Wondfo Biotech Co. Ltd. – Product and service
• 75: Guangzhou Wondfo Biotech Co. Ltd. – Key offerings
• 76: Guangzhou Wondfo Biotech Co. Ltd. – Key customers
• 77: Guangzhou Wondfo Biotech Co. Ltd. – Segment focus
• 78: Maccura Biotechnology Co. Ltd. – Overview
• 79: Maccura Biotechnology Co. Ltd. – Product and service
• 80: Maccura Biotechnology Co. Ltd. – Key offerings
• 81: Maccura Biotechnology Co. Ltd. – Key customers
• 82: Maccura Biotechnology Co. Ltd. – Segment focus
• 83: Mylab Discovery Solutions Pvt Ltd. – Overview
• 84: Mylab Discovery Solutions Pvt Ltd. – Product and service
• 85: Mylab Discovery Solutions Pvt Ltd. – Key offerings
• 86: Mylab Discovery Solutions Pvt Ltd. – Key customers
• 87: Mylab Discovery Solutions Pvt Ltd. – Segment focus
• 88: QIAGEN NV – Overview
• 89: QIAGEN NV – Business segments
• 90: QIAGEN NV – Key offerings
• 91: QIAGEN NV – Key customers
• 92: QIAGEN NV – Segment focus
• 93: Thermo Fisher Scientific Inc. – Overview
• 94: Thermo Fisher Scientific Inc. – Business segments
• 95: Thermo Fisher Scientific Inc. – Key offerings
• 96: Thermo Fisher Scientific Inc. – Key customers
• 97: Thermo Fisher Scientific Inc. – Segment focus
• 98: Currency conversion rates for US$
• 99: Research Methodology
• 100: Validation techniques employed for market sizing
• 101: Information sources
• 102: List of abbreviations



【掲載企業】

3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co Diagnostics Inc., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[新型コロナウイルス感染症検査キットのアジア太平洋市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆